HAL Allergy, for those who drive pharmaceutical innovation. Do you?
HAL Allergy is one of the European top players in the development, production and distribution of allergen immunotherapies for the treatment and prevention of allergic diseases. With all our activities the patient’s well-being is always our top priority. At our headquarters in the Leiden Bio Science Park (NL) we focus on the development and manufacturing of (modified) allergen extracts for the therapeutic and diagnostic purposes of respiratory and food allergies.